Abstract

Lipoma is a benign tumor consisting of mature adipocyte tissue that grows abnormally. This case study aims to determine about treatment and diagnosis of lipoma in dog. The animal in this case is a female mixed Labrador and Pomeranian dog, 11 years old, weighing 17.6 kg with complaints of a large mass that hang in the area of the hind limb. Supportive examination was carried out by histopathological examination. The presence of tumor cells in the form of spindle cells, homogeneous maturation of lipid cell poiferation were found. Based on its medical history, clinical examination, and laboratory examination, the dog was diagnosed with Lipoma. Premedication was given in the form of atropine sulfate at a dose of 0.02 mg/kg BW (SC), and anesthesia in the form of a combination of xylazine at a dose of 2 mg/kg of BW and ketamine at a dose of 13 mg/kg BW (IM). Surgery was performed with excision of the tumor mass in the hind leg area. Postoperatively, the antibiotic cefotaxime was given at a dose of 20 mg/kg of BW (IM), followed by administration of cefixime trihydrate syrup 100 mg/5ml at a dose of 10 mg/kg BW by PO for five days and anti-inflammatory tolfenamic acid at a dose of 4 mg/kg BW by SC for three days. Neomycin Sulfate powder was given sufficiently until the wound dries. On the 12th day of postoperative, the wound fused and there were no complications. In conclusion, based on the anamnesis and all supportive examinations, the dog was diagnosed with lipoma on hind legs, and was treated with tumor tissue excision. The dog’s condition was observed to be stable, and no other complaints were reported post-treatment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.